Are you curious about how novel discoveries make their way from the bench to the clinic? Interested in transitioning from academia to industry? If so, please join us for the next seminar in our Business of Science Series on April 25, 2013, where we are thrilled to be hosting Dr. Thomas Kodadek of the Scripps Institute Florida.
Thomas Kodadek, Ph.D., the fifth speaker in our ‘Business of Science’ seminar series, is a Professor and Chair of the Department of Chemistry at the Scripps Research Institute, Florida, and a member of the Scientific Advisory Board of Opko Diagnostics, a Miami-based biotechnology company. A leader in the field of chemical biology, Dr. Kodadek’s lab specializes in developing novel tools and screening technologies for early detection and diagnosis of neurodegenerative diseases and cancer, and is also working to develop new treatment strategies for autoimmune diseases. Among his many honors, in 2006 Dr. Kodadek received a NIH Director’s Pioneer Award for “exceptionally creative research.” Following Dr. Kodadek’s lecture “The Ups & Downs of Moving ‘Disruptive’ Diagnostic and Therapeutic Technology from the Lab to the ‘Real World’”, we will host a networking event with local businesses. Please join us to hear about Dr. Kodadek’s exciting research and his experiences in moving his technologies to the real world!
Previous events in this special seminar series include:
Scientific Collaboration in the Development of New Drugs: The Path to Progress and Innovation in the Pharmaceutical Industry
Jack Henion, Ph.D. Co-Founder, Chief Scientific Officer and Chairman, Advion, Inc. (April 24th, 2012)
The Business of Science I: Careers in Industrial Settings
Tom Baughman, Technology Licensing Associate, UT Austin Office of Technology Commercialization and Gregory Ippolito, Ph.D. Research Associate, Section of Molecular Genetics and Microbiology, UT Austin and Former Director of Preclinical Research & Development, XBiotech USA (April 19th, 2011)